lgg101

Leonard Gomella, MD

Contact Dr. Gomella

1025 Walnut Street
Suite 1112
Philadelphia, PA 19107

(215) 955-6961
(215) 923-1884 fax

Most Recent Peer-reviewed Publications

  1. The perlecan-interacting growth factor progranulin regulates ubiquitination, sorting, and lysosomal degradation of sortilin
  2. Intravesical rAd–IFNa/Syn3 for patients with high-grade, bacillus calmette-guerin–refractory or relapsed non–muscle-invasive bladder cancer: A phase II randomized study
  3. VAPC-1 Targeted64Cu-TP3805 kit preparation and its evaluation
  4. Prostate MRI: Value in surgical planning?
  5. Nonpalpable intratesticular mass in a young man with a history of contralateral retractile testis
  6. The urology guide to coffee and tea
  7. Development of a voided urine assay for detecting prostate cancer non-invasively: a pilot study
  8. Prevalence and Characteristics of Patients with Suspected Inherited Renal Cell Cancer: Application of the ACMG/NSGC Genetic Referral Guidelines to Patient Cohorts
  9. The Role of Therapeutic Layering in Optimizing Treatment for Patients With Castration-resistant Prostate Cancer (Prostate Cancer Radiographic Assessments for Detection of Advanced Recurrence II)
  10. The liquid biopsy for prostate cancer 25 years later
  11. Editorial Comment
  12. Prostate cancer statistics: Anything you want them to be
  13. Where have all the sperm gone?
  14. Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: The largest single-institution experience to date
  15. Hematologic Toxicity of Concurrent Administration of Radium-223 and Next-generation Antiandrogen Therapies
  16. Decipher correlation patterns post prostatectomy: Initial experience from 2 342 prospective patients
  17. Clinical Influences in the Multidisciplinary Management of Small Renal Masses at a Tertiary Referral Center
  18. Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case Report
  19. An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care
  20. Low Incidence of Corticosteroid-associated Adverse Events on Long-term Exposure to Low-dose Prednisone Given with Abiraterone Acetate to Patients with Metastatic Castration-resistant Prostate Cancer